In Stock
Pazopanib Tablets
Pazopanib Tablets 400mg | Anti-Cancer
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
Generic medicine information • For patient education
Product Introduction
Pazopanib 400 mg is a prescription anti-cancer medicine belonging to the protein kinase inhibitor (tyrosine kinase inhibitor) class. It is used for selected patients with kidney cancer and soft tissue sarcoma. Your oncology specialist will decide whether it is appropriate based on your diagnosis, treatment history, and current prescribing information.
The 400 mg strength is the amount in one tablet; it does not determine how many tablets you should take. Follow the exact dose and schedule prescribed by your oncologist.
1. Uses
Kidney cancer (renal cell carcinoma) in selected patients.
Soft tissue sarcoma in selected patients, according to the approved indication and previous treatment history.
Your oncologist will confirm the specific indication and treatment plan for your condition.
2. Benefits
Blocks tyrosine kinase enzymes involved in cancer-cell growth and survival.
Restricts signals that help tumours develop new blood vessels.
In appropriately selected patients, it may help control cancer growth or slow disease progression. The benefit varies by patient and it is not a guaranteed cure.
3. Side Effects
Common side effects may include diarrhoea, high blood pressure, nausea, vomiting, reduced appetite, weight loss, fatigue, changes in hair colour, taste changes, and changes in blood counts.
Serious risks can include severe liver injury, high blood pressure, abnormal heart rhythm or QT prolongation, bleeding, blood clots, heart problems, thyroid problems, impaired wound healing, and rarely gastrointestinal perforation.
Seek urgent medical advice for yellow skin or eyes, dark urine, severe tiredness, persistent vomiting, severe abdominal pain, unusual bleeding, black stools, chest pain, sudden breathlessness, fainting, severe headache or confusion, or a severe skin reaction.
4. Safety Advice
Tell your oncology team if you have liver or kidney disease, heart disease, high blood pressure, thyroid problems, bleeding problems, or a planned surgery.
Regular monitoring may include blood pressure, liver function tests, blood counts, thyroid function, and other tests as advised by your clinician. Liver injury can be serious, so attend all scheduled tests.
Pregnancy: pazopanib may cause serious harm to an unborn baby. Do not use it during pregnancy or if planning pregnancy; discuss reliable contraception with your oncology team.
Breastfeeding: do not breastfeed during treatment. Ask your specialist when it may be safe to resume.
Surgery and dental procedures: tell your surgeon or dentist that you take pazopanib because it may delay wound healing. Your oncology team may advise a treatment pause.
Driving: avoid driving or operating machinery if you feel dizzy, sleepy, weak, or have vision changes.
Alcohol: ask your clinician whether alcohol is appropriate during treatment.
Storage: store below 30°C, in the original packaging and out of reach of children, unless the package leaflet says otherwise.
5. How It Works
Pazopanib inhibits several tyrosine kinase receptors involved in cancer-cell growth and the development of blood vessels that supply tumours. By blocking these signals, it can slow the growth and spread of certain cancers.
6. How to Use
Take exactly as prescribed by your oncologist. Swallow the tablet whole with water; do not crush, chew, or break it.
Take on an empty stomach: at least 1 hour before food or 2 hours after food. Taking it with food can change how much medicine is absorbed.
Try to take it at the same time each day. Do not change the dose or stop treatment without consulting your oncologist.
If you miss a dose, follow the package leaflet or contact your oncology team. Do not take an extra dose to make up for a missed dose.
Avoid grapefruit and grapefruit juice during treatment.
7. Quick Tips
Check your blood pressure regularly as advised by your healthcare team.
Attend all scheduled blood tests, particularly liver-function monitoring.
Drink fluids if diarrhoea occurs and contact your care team if it is persistent, severe, bloody, or accompanied by dehydration.
Report yellowing of the skin or eyes, dark urine, unusual tiredness, abdominal pain, or unusual bleeding promptly.
Tell your doctor about all medicines and supplements. Do not take antacids or acid-reducing medicines such as H2 blockers or proton-pump inhibitors unless your oncology team has reviewed them, because they can affect pazopanib absorption.
Be careful with sharp objects and report wounds that heal slowly.
8. Drug Interactions
Pazopanib has important interactions with medicines that affect heart rhythm, liver enzymes, stomach acidity, or bleeding risk.
Examples requiring professional review include amiodarone, escitalopram, haloperidol, ondansetron, iloperidone, and medicines that reduce stomach acid. This is not a complete list.
Do not start, stop, or change any prescription medicine, over-the-counter medicine, or supplement without checking with your oncologist or pharmacist.
Medical Disclaimer
This document is for general patient education only and is not a substitute for advice from a qualified doctor, oncology specialist, or pharmacist. Pazopanib is a prescription anti-cancer medicine and must be used only under specialist supervision. The correct indication, dose, food timing, monitoring, precautions, and management of side effects depend on the individual patient and current approved product information. In an emergency, seek urgent medical care.
| Product Name | Pazopanib Tablets |
| Category | All Medicines, Anti Cancer |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 400mg |
|---|
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
